Slideshow

Key Concepts About Polypharmacy in Psychotic Disorders

Author(s):

Jose M. Rubio, MD

Clinicians should keep in mind the risk-to-benefit ratio considerations before initiating polypharmacy, especially if they have patients with prescriptions inherited from several sources. Here: A summary of recommendations about the use of polypharmacy in psychotic disorders.

Related Videos
Christoph U. Correll
John Kane
clozapine
40 years
Andrii Yalaanskyi/AdobeStock
Tierney/AdobeStock
VectorStory/AdobeStock
Related Content
schizophrenia
March 31st 2025

Additional Positive Data on LB-102 for the Treatment of Acutely Exacerbated Schizophrenia

Leah Kuntz
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
smoking
March 27th 2025

In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network Function

Heather Burrell Ward, MD
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
schizophrenia
March 10th 2025

How the Study of Muscarinic Receptors Is Transforming Schizophrenia Treatment

Khutaija Noor, MBBS, FCR
postpartum
March 7th 2025

Tragic or Treated: Why We Cannot Miss Postpartum Psychosis

Meghan Cliffel Susan Hatters Friedman, MD, MSt, DFAPA
© 2025 MJH Life Sciences

All rights reserved.